Indian Manufacturers Rush to Fill Ozempic Gap Amid Patent Expiration
Indian drugmakers have slashed prices of semaglutide-based weight-loss injections like Ozempic by up to 90% since the patent expired on March 20, 2026, making them accessible to millions battling obesity—a ... Read More